BVXV logo

BiondVax Pharmaceuticals (BVXV) Current Liabilities

Annual Current Liabilities

$2.34 M
-$106.00 K-4.34%

December 31, 2022


Summary


Performance

BVXV Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBVXVbalance sheetmetrics:

Quarterly Current Liabilities

$1.89 M
-$691.00 K-26.79%

June 30, 2023


Summary


Performance

BVXV Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBVXVbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

BVXV Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.3%-72.1%
3 y3 years-57.3%+2.4%
5 y5 years+18.1%+228.4%

BVXV Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-4.3%at low-72.1%-22.1%
5 y5-year-88.3%at low-91.3%-29.3%
alltimeall time-88.3%-88.9%-91.3%-86.7%

BiondVax Pharmaceuticals Current Liabilities History

DateAnnualQuarterly
Jun 2023
-
$1.89 M(-26.8%)
Mar 2023
-
$2.58 M(+10.3%)
Dec 2022
$2.34 M(-4.3%)
$2.34 M(+58.9%)
Sep 2022
-
$1.47 M(-78.3%)
Jun 2022
-
$6.77 M(+153.4%)
Mar 2022
-
$2.67 M(+9.4%)
Dec 2021
$2.44 M(-87.8%)
$2.44 M(-88.8%)
Sep 2021
-
$21.82 M(+2.4%)
Jun 2021
-
$21.31 M(+6.7%)
Mar 2021
-
$19.98 M(+0.1%)
Dec 2020
$19.96 M(+264.6%)
$19.96 M(+517.1%)
Sep 2020
-
$3.23 M(+75.5%)
Jun 2020
-
$1.84 M(+38.0%)
Mar 2020
-
$1.34 M(-75.6%)
Dec 2019
$5.47 M(-5.4%)
$5.47 M(+521.5%)
Sep 2019
-
$881.00 K(-68.5%)
Jun 2019
-
$2.80 M(-40.9%)
Mar 2019
-
$4.74 M(-18.1%)
Dec 2018
$5.79 M
$5.79 M(+670.7%)
DateAnnualQuarterly
Sep 2018
-
$751.00 K(+30.6%)
Jun 2018
-
$574.90 K(-78.3%)
Mar 2018
-
$2.65 M(+33.6%)
Dec 2017
$1.98 M(+454.0%)
$1.98 M(+122.9%)
Sep 2017
-
$888.50 K(+67.3%)
Jun 2017
-
$531.00 K(+50.6%)
Mar 2017
-
$352.70 K(-1.3%)
Dec 2016
$357.50 K(-17.9%)
$357.50 K(+42.3%)
Sep 2016
-
$251.20 K(-16.1%)
Jun 2016
-
$299.30 K(-28.0%)
Mar 2016
-
$415.50 K(-4.5%)
Dec 2015
$435.20 K(-6.5%)
$435.20 K(+28.7%)
Sep 2015
-
$338.20 K(-12.6%)
Jun 2015
-
$387.10 K(-6.3%)
Mar 2015
-
$413.00 K(-11.3%)
Dec 2014
$465.60 K(-9.0%)
$465.60 K(+18.0%)
Sep 2014
-
$394.50 K(-22.9%)
Dec 2013
$511.70 K(+97.3%)
$511.70 K
Dec 2012
$259.40 K
-

FAQ

  • What is BiondVax Pharmaceuticals annual total current liabilities?
  • What is the all time high annual current liabilities for BiondVax Pharmaceuticals?
  • What is BiondVax Pharmaceuticals annual current liabilities year-on-year change?
  • What is BiondVax Pharmaceuticals quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for BiondVax Pharmaceuticals?
  • What is BiondVax Pharmaceuticals quarterly current liabilities year-on-year change?

What is BiondVax Pharmaceuticals annual total current liabilities?

The current annual current liabilities of BVXV is $2.34 M

What is the all time high annual current liabilities for BiondVax Pharmaceuticals?

BiondVax Pharmaceuticals all-time high annual total current liabilities is $19.96 M

What is BiondVax Pharmaceuticals annual current liabilities year-on-year change?

Over the past year, BVXV annual total current liabilities has changed by -$106.00 K (-4.34%)

What is BiondVax Pharmaceuticals quarterly total current liabilities?

The current quarterly current liabilities of BVXV is $1.89 M

What is the all time high quarterly current liabilities for BiondVax Pharmaceuticals?

BiondVax Pharmaceuticals all-time high quarterly total current liabilities is $21.82 M

What is BiondVax Pharmaceuticals quarterly current liabilities year-on-year change?

Over the past year, BVXV quarterly total current liabilities has changed by -$4.89 M (-72.13%)